These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1842668)

  • 1. Adverse reaction reporting of interaction between warfarin and fluoroquinolones.
    Jolson HM; Tanner LA; Green L; Grasela TH
    Arch Intern Med; 1991 May; 151(5):1003-4. PubMed ID: 1842668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evaluation of the quinolone-theophylline interaction using the Food and Drug Administration spontaneous reporting system.
    Grasela TH; Dreis MW
    Arch Intern Med; 1992 Mar; 152(3):617-21. PubMed ID: 1312320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions.
    Wysowski DK; Swartz L
    Arch Intern Med; 2005 Jun; 165(12):1363-9. PubMed ID: 15983284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bleeding complications with warfarin use: a prevalent adverse effect resulting in regulatory action.
    Wysowski DK; Nourjah P; Swartz L
    Arch Intern Med; 2007 Jul; 167(13):1414-9. PubMed ID: 17620536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse behavioral reactions attributed to triazolam in the Food and Drug Administration's Spontaneous Reporting System.
    Wysowski DK; Barash D
    Arch Intern Med; 1991 Oct; 151(10):2003-8. PubMed ID: 1929688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ciprofloxacin and norfloxacin, two fluoroquinolone antimicrobials.
    Nix DE; DeVito JM
    Clin Pharm; 1987 Feb; 6(2):105-17. PubMed ID: 3311572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between warfarin and three commonly prescribed fluoroquinolones.
    Carroll DN; Carroll DG
    Ann Pharmacother; 2008 May; 42(5):680-5. PubMed ID: 18413687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diplopia and fluoroquinolones.
    Fraunfelder FW; Fraunfelder FT
    Ophthalmology; 2009 Sep; 116(9):1814-7. PubMed ID: 19643481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National adverse drug reaction reporting. 1984-1989.
    Faich GA
    Arch Intern Med; 1991 Aug; 151(8):1645-7. PubMed ID: 1872669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential glucosamine-warfarin interaction resulting in increased international normalized ratio: case report and review of the literature and MedWatch database.
    Knudsen JF; Sokol GH
    Pharmacotherapy; 2008 Apr; 28(4):540-8. PubMed ID: 18363538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physician knowledge, attitudes, and behavior related to reporting adverse drug events.
    Rogers AS; Israel E; Smith CR; Levine D; McBean AM; Valente C; Faich G
    Arch Intern Med; 1988 Jul; 148(7):1596-600. PubMed ID: 3382304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and predictors of potential drug-drug interactions in Regione Emilia-Romagna, Italy.
    Gagne JJ; Maio V; Rabinowitz C
    J Clin Pharm Ther; 2008 Apr; 33(2):141-51. PubMed ID: 18315779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interaction between warfarin and nalidic acid].
    Gulløv AL; Koefoed BG; Petersen P
    Ugeskr Laeger; 1996 Sep; 158(37):5174-5. PubMed ID: 8848852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Norfloxacin does not alter warfarin's disposition or anticoagulant effect.
    Rocci ML; Vlasses PH; Distlerath LM; Gregg MH; Wheeler SC; Zing W; Bjornsson TD
    J Clin Pharmacol; 1990 Aug; 30(8):728-32. PubMed ID: 2401751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced hypoprothrombinemia with warfarin due to azithromycin.
    Rao KB; Pallaki M; Tolbert SR; Hornick TR
    Ann Pharmacother; 2004 Jun; 38(6):982-5. PubMed ID: 15084685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of drug interactions on outcomes of patients receiving warfarin or theophylline.
    Jankel CA; McMillan JA; Martin BC
    Am J Hosp Pharm; 1994 Mar; 51(5):661-6. PubMed ID: 8203385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ciprofloxacin-warfarin coagulopathy: a case series.
    Ellis RJ; Mayo MS; Bodensteiner DM
    Am J Hematol; 2000 Jan; 63(1):28-31. PubMed ID: 10602164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of a data mining signal for amyotrophic lateral sclerosis and statins detected in FDA's spontaneous adverse event reporting system.
    Colman E; Szarfman A; Wyeth J; Mosholder A; Jillapalli D; Levine J; Avigan M
    Pharmacoepidemiol Drug Saf; 2008 Nov; 17(11):1068-76. PubMed ID: 18821724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between miconazole oral gel (Daktarin) and warfarin.
    Pillans P; Woods DJ
    N Z Med J; 1996 Sep; 109(1029):346. PubMed ID: 8862358
    [No Abstract]   [Full Text] [Related]  

  • 20. National adverse drug reaction surveillance. 1986.
    Faich GA; Dreis M; Tomita D
    Arch Intern Med; 1988 Apr; 148(4):785-7. PubMed ID: 3355297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.